Gadicke Ansbert
- SEC CIK
- 0001134655
In the past year, 1 open-market purchase filing worth $20.0M and 12 sale filings worth $5.36M.
Current role at each company
- TRDA Entrada Therapeutics, Inc.10% Owneras of Sep 9, 2026
- AKTS Aktis Oncology, Inc.10% Owneras of Jan 14, 2026
- HOWL Werewolf Therapeutics, Inc.Other: Former 10% Owneras of Dec 4, 2025
- ITOS iTeos Therapeutics, Inc.Other: Former 10% Owneras of May 15, 2025
- TCRR TCR2 Therapeutics Inc.Director, 10% Owneras of Jun 5, 2023
Show 3 more companies
- KLRS Kalaris Therapeutics, Inc.Director, 10% Owneras of Aug 1, 2022
- CGEM Cullinan Therapeutics, Inc.Directoras of Jun 23, 2022
- RPTX Repare Therapeutics Inc.10% Owneras of Jul 13, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $20.0M
- 1 filing
- Sold
- $5.36M
- 12 filings
- Net
- +$14.7M
- Bought minus sold
- Companies
- 3
- With open-market trades
Trades
Every Form 4 that lists Gadicke Ansbert as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TRDA Entrada Therapeutics, Inc.
10% Owner6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 (view filing)5:37 PM ET | Nov 2 | 2 days | Gadicke Ansbert and 8 others10% Owner | PPurchase | +100.0K | $20.00 | +$2.00M | +2.3%4.43M after | Duplicate filing |
| Dec 12, 2024 (view filing)5:00 PM ET | Dec 10-11 | 2 days | Gadicke Ansbert and 9 others10% Owner | SSale | −44.7K | $20.51 | −$917.1K | −1.0%4.38M after | 2 lots |
| Aug 26, 2026 (view filing)9:28 PM ET | Aug 24-26 | 2 days | Gadicke Ansbert and 9 others10% Owner | SSale | −62.7K | $7.36 | −$461.5K | −1.4%4.32M after | 3 lotsDuplicate filing |
| Aug 31, 2026 (view filing)6:25 PM ET | Aug 27-31 | 4 days | Gadicke Ansbert and 9 others10% Owner | SSale | −86.9K | $7.08 | −$615.8K | −2.0%4.23M after | 3 lots |
| Sep 3, 2026 (view filing)7:21 PM ET | Sep 1-3 | 2 days | Gadicke Ansbert and 9 others10% Owner | SSale | −86.5K | $7.14 | −$617.4K | −2.0%4.14M after | 3 lots |
| Sep 9, 2026 (view filing)7:23 PM ET | Sep 4-9 | 5 days | Gadicke Ansbert and 9 others10% Owner | SSale | −259.8K | $7.33 | −$1.91M | −6.3%3.89M after | 3 lots |
AKTS Aktis Oncology, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 (view filing)6:17 PM ET | Jan 12 | 2 days | Gadicke Ansbert and 2 others10% Owner | PPurchase | +1.11M | $18.00 | +$20.0M | +12.2%10.3M after |
HOWL Werewolf Therapeutics, Inc.
Other: Former 10% Owner10 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2025 (view filing)4:08 PM ET | Mar 27 | 34 daysLate | Gadicke Ansbert and 6 others10% Owner | SSale | −4.39K | $1.05 | −$4.61K | −0.1%6.72M after | |
| Oct 29, 2025 (view filing)7:21 PM ET | Oct 27-29 | 2 days | Gadicke Ansbert and 6 others10% Owner | SSale | −276.0K | $1.62 | −$446.4K | −4.1%6.44M after | 3 lots10b5-1 |
| Nov 3, 2025 (view filing)7:07 PM ET | Oct 30-Nov 3 | 4 days | Gadicke Ansbert and 6 others10% Owner | SSale | −295.0K | $1.33 | −$391.6K | −4.6%6.15M after | 3 lots10b5-1 |
| Nov 6, 2025 (view filing)7:40 PM ET | Nov 4-6 | 2 days | Gadicke Ansbert and 6 others10% Owner | SSale | −242.9K | $1.22 | −$295.8K | −4.0%5.90M after | 3 lots10b5-1 |
| Nov 12, 2025 (view filing)7:31 PM ET | Nov 7-12 | 5 days | Gadicke Ansbert and 6 others10% Owner | SSale | −213.5K | $1.13 | −$241.3K | −3.6%5.69M after | 4 lots10b5-1 |
| Nov 17, 2025 (view filing)7:20 PM ET | Nov 13-17 | 4 days | Gadicke Ansbert and 6 others10% Owner | SSale | −209.7K | $0.9571 | −$200.7K | −3.7%5.48M after | 3 lots10b5-1 |
| Nov 20, 2025 (view filing)5:50 PM ET | Nov 18-20 | 2 days | Gadicke Ansbert and 6 others10% Owner | SSale | −160.1K | $0.9239 | −$147.9K | −2.9%5.32M after | 3 lots10b5-1 |
| Nov 25, 2025 (view filing)6:03 PM ET | Nov 21-25 | 4 days | Gadicke Ansbert and 6 others10% Owner | SSale | −195.7K | $0.9176 | −$179.6K | −3.7%5.13M after | 3 lots10b5-1 |
| Dec 1, 2025 (view filing)6:11 PM ET | Nov 26-Dec 1 | 5 days | Gadicke Ansbert and 6 others10% Owner | SSale | −141.9K | $0.9643 | −$136.9K | −2.8%4.98M after | 3 lots10b5-1 |
| Dec 4, 2025 (view filing)6:18 PM ET | Dec 2-4 | 2 days | Gadicke Ansbert and 6 othersOther: Former 10% Owner | SSale | −199.7K | $0.9176 | −$183.3K | −4.0%4.78M after | 3 lots10b5-1 |
ITOS iTeos Therapeutics, Inc.
Other: Former 10% Owner17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2021 (view filing)7:19 PM ET | Sep 7-8 | 1 day | Gadicke Ansbert and 3 others10% Owner | SSale | −71.2K | $29.03 | −$2.07M | −1.2%5.90M after | 3 lots |
| Sep 13, 2021 (view filing)7:02 PM ET | Sep 9-13 | 4 days | Gadicke Ansbert and 3 others10% Owner | SSale | −96.5K | $28.32 | −$2.73M | −1.6%5.81M after | 4 lots |
| Sep 16, 2021 (view filing)4:46 PM ET | Sep 14-15 | 2 days | Gadicke Ansbert and 3 others10% Owner | SSale | −76.4K | $27.70 | −$2.12M | −1.3%5.73M after | 4 lots |
| Sep 20, 2021 (view filing)6:30 PM ET | Sep 16-20 | 4 days | Gadicke Ansbert and 3 others10% Owner | SSale | −152.7K | $28.38 | −$4.33M | −2.7%5.58M after | 4 lots |
| Sep 23, 2021 (view filing)4:18 PM ET | Sep 21-22 | 2 days | Gadicke Ansbert and 3 others10% Owner | SSale | −56.8K | $27.50 | −$1.56M | −1.0%5.52M after | 2 lots |
| Sep 27, 2021 (view filing)5:51 PM ET | Sep 23-27 | 4 days | Gadicke Ansbert and 3 others10% Owner | SSale | −89.5K | $27.76 | −$2.48M | −1.6%5.43M after | 4 lots |
| Sep 30, 2021 (view filing)5:05 PM ET | Sep 28-30 | 2 days | Gadicke Ansbert and 3 others10% Owner | SSale | −36.0K | $27.00 | −$971.7K | −0.7%5.39M after | 2 lots |
| Oct 5, 2021 (view filing)4:31 PM ET | Oct 1-4 | 4 days | Gadicke Ansbert and 3 others10% Owner | SSale | −46.1K | $27.05 | −$1.25M | −0.9%5.35M after | 2 lots |
| Oct 12, 2021 (view filing)4:33 PM ET | Oct 7-11 | 5 days | Gadicke Ansbert and 3 others10% Owner | SSale | −87.0K | $27.23 | −$2.37M | −1.6%5.26M after | 3 lots |
| Oct 14, 2021 (view filing)5:26 PM ET | Oct 12-14 | 2 days | Gadicke Ansbert and 3 others10% Owner | SSale | −95.0K | $27.21 | −$2.58M | −1.8%5.17M after | 3 lots |
TCRR TCR2 Therapeutics Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 24, 2023 (view filing) | May 22 | 2 days | Gadicke AnsbertDirector, 10% Owner | SSale | −70.2K | $1.88 | −$131.9K | −18.8%304.0K after |
CGEM Cullinan Therapeutics, Inc.
Director16 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2021 (view filing) | Aug 11 | 1 day | Gadicke AnsbertDirector, 10% Owner | SSale | −347 | $29.05 | −$10.1K | −0.1%280.9K after | |
| Aug 12, 2021 (view filing) | Aug 11 | 1 day | Gadicke AnsbertDirector, 10% Owner | SSale | −2.51K | $29.05 | −$72.9K | 0.0%7.91M after | |
| Aug 25, 2021 (view filing) | Aug 23-25 | 2 days | Gadicke AnsbertDirector, 10% Owner | SSale | −14.6K | $29.29 | −$428.7K | −5.2%266.3K after | 3 lots |
| Aug 25, 2021 (view filing) | Aug 23-25 | 2 days | Gadicke AnsbertDirector, 10% Owner | SSale | −106.0K | $29.29 | −$3.10M | −1.3%7.81M after | 3 lots |
| Aug 31, 2021 (view filing) | Aug 27-30 | 4 days | Gadicke AnsbertDirector, 10% Owner | SSale | −6.13K | $29.24 | −$179.3K | −2.3%260.2K after | 2 lots |
| Aug 31, 2021 (view filing) | Aug 27-30 | 4 days | Gadicke AnsbertDirector, 10% Owner | SSale | −44.4K | $29.24 | −$1.30M | −0.6%7.76M after | 2 lots |
| Sep 2, 2021 (view filing) | Aug 31-Sep 2 | 2 days | Gadicke AnsbertDirector, 10% Owner | SSale | −3.36K | $29.50 | −$99.1K | −1.3%256.8K after | 4 lots |
| Sep 2, 2021 (view filing) | Aug 31-Sep 2 | 2 days | Gadicke AnsbertDirector, 10% Owner | SSale | −24.3K | $29.50 | −$717.2K | −0.3%7.74M after | 4 lots |
| Sep 8, 2021 (view filing) | Sep 3-8 | 5 days | Gadicke AnsbertDirector, 10% Owner | SSale | −6.72K | $29.20 | −$196.4K | −2.6%250.1K after | 3 lots |
| Sep 8, 2021 (view filing) | Sep 3-8 | 5 days | Gadicke AnsbertDirector, 10% Owner | SSale | −48.6K | $29.20 | −$1.42M | −0.6%7.69M after | 3 lots |
RPTX Repare Therapeutics Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2021 (view filing) | Jul 9-12 | 4 days | Gadicke Ansbert10% Owner | SSale | −62.1K | $33.55 | −$2.08M | −1.6%3.88M after | 3 lots |